inoculations of IgA (total dose of 1.5 mg Ab per mouse) was unable to suppress a lethal blood stage challenge infection in these animals in contrast to previous observations with the epitope-matched human IgG1 passively administered into human FcγRI (CD64) transgenic animals [3] (Figure 3). This evidence concerns the gene CD79A and infection.